The potency and specificity of killing capacity of CD19.CAR-T cells were assessed by a standard Calcein AM assay, showing high cytotoxicity against CD19+ tumor cells but negligible activity against CD19- K562 cells (Supplementary Figure 2E). This evidence concerns the gene CD19 and neoplasm.